Overview PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia Status: Completed Trial end date: 2016-02-01 Target enrollment: Participant gender: Summary The purpose of this study is to estimate the efficacy and safety of PEG-rhG-CSF in patients with breast cancer receiving chemotherapy. Phase: Phase 4 Details Lead Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.